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ABSTRACT
Objective: Diabetes mellitus (DM) is a common health problem in the world. Free iron may contribute to the pathogenesis and progress of this 
disease and its complication. Iron causes hyperinsulinemia by decreasing the insulin uptake and metabolism by hepatocytes. Elevated iron stores are 
commonly found in insulin resistance. Iron in its free form is known to induce oxidation of biomolecules by producing harmful hydroxyl radicals. In 
this study, we aimed to estimate and compare the serum levels of free iron in diabetes and healthy individuals.
Methods: This study included 244 subjects in two groups. Group-I comprised 204 subjects with DM and Group-II comprised 40 healthy subjects. Blood 
sugar, free iron, and glycated hemoglobin were analyzed in blood samples using standard kits. The results of all the parameters were expressed as 
mean±standard deviation. Student t-test was done to assess the statistical significance between two groups. The association between the parameters 
was studied by Pearson correlation.
Results: In this study, we found a significant increase in serum free iron in Group-I (p<0.01) when compared with Group-II. A significant correlation 
between the serum free iron and glycated hemoglobin (r=0.59; p<0.001) and fasting blood sugar (r=0.43; p<0.001).
Conclusion: The elevated serum free iron in uncontrolled diabetes may contribute to oxidative stress which may be associated with complications 
of diabetes.
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INTRODUCTION
Iron is a very important transition metal for the cells in the body, and its 
abnormal homeostasis is associated with the pathogenesis of various 
chronic diseases, including diabetes [1,2]. Iron plays a key role in vital 
biochemical activities [3]. Iron is potentially hazardous because of its 
ability to participate in the generation of powerful oxidant species such 
as hydroxyl radical [4,5]. Dietary iron is a critical determinant of body’s 
iron status since once absorbed it is not actively excreted [6,7]. However, 
the ability of iron to cycle between its two stable oxidation states is also 
potentially to generate reactive oxygen or nitrogen species (ROS or RNS) 
such as hydroxyl radical via Fenton’s and Haber–Weiss reactions [3,6,8]. 
To control and balance the production of ROSs and RNSs, the cell builds 
up a set of antioxidants and detoxifying enzymes such as superoxide 
dismutase, catalyze, and glutathione peroxidase that can scavenge 
excessive ROSs or RNSs beyond the antioxidant capacity of the organism 
called oxidative stress is encountered in many pathological conditions 
such as diabetes and diabetic complications [3,6,9,10]. Iron can be 
released from ferritin by the action of reducing agents that convert Fe3+ 
into Fe2+ [11,12]. Apoferritin, the protein fraction of ferritin that holds 
oxidized iron molecules. When the concentrations of antioxidants are 
low, the reducing potential and anaerobiosis progressively increase, 
facilitating a rapid release of iron from ferritin. The overall result of 
oxidative reactions is an increase in the availability of free iron from 
the ferritin [11,13]. Iron influences insulin action and it interferes with 
insulin inhibition of glucose production by the liver [11,14-16]. Hepatic 
extraction and metabolism of insulin are reduced with increasing iron 
stores, leading to peripheral hyperinsulinemia. In fact, the initial and 
most common abnormality seen in iron overload conditions is liver 
insulin resistance [11,15].
The exact mechanism of iron-induced diabetes is mediated by 3 
key mechanisms: “Insulin deficiency, insulin resistance, and hepatic 
dysfunction” [4,17]. The mechanisms for insulin resistance include 
the possibility of iron overload causing resistance directly or through 
hepatic dysfunction. Patients with unexplained hepatic iron overload 
mostly found to be insulin resistant, which suggests a common etiologic 
link among hepatic iron, hepatic dysfunction, and insulin resistance 
[18]. This study was aimed to determine serum free iron in person with 
diabetes and healthy individuals.
METHODS
This study was done at the Department of Biochemistry, Sri 
Ramachandra Medical College and Research Institute, Chennai - 116, 
and it was approved by our Institutional Ethical Committee (REF: 
CSP/12/JUL/24/111).
Selection of participants
The total number of subjects was 244. Study subjects were categorized 
into 2 groups.
Diabetes mellitus (DM) group consists of 204 subjects. The exclusion 
criteria are Type-I DM, hyperthyroidism, cancer, and pancreatitis. 
Inclusion criteria are Type-2 DM >30 years of age.
The healthy group consists of 40 subjects. Exclusion criteria are 
smokers, alcoholics, pregnant and lactating women. The inclusion 
criteria are >30 years of healthy persons without any disease.
Sample type
Serum, plasma, and whole blood.
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Sample collection
The blood sample from 244 individuals was collected in fasting 
state using vacutainers with sodium fluoride and EDTA and without 
anticoagulants sterile gel tube. These tubes were centrifuged at 
3500 rpm for 10 minutes, and serum was separated.
Blood sample analysis
Fasting blood sugar (FBS) by hexokinase method and free iron by direct 
iron assay using chromophore ferene® were analyzed in blood sample 
using standard kits in Dimension RxL autoanalyzer, USA, and glycated 
hemoglobin (HbA1c) by high-performance liquid chromatography 
method was analyzed in blood sample using Bio-rad autoanalyzer, USA. 
Glucose present in plasma in expressed as mg/dl. Iron present in serum 
is expressed as µg%. HbA1c present in whole blood is expressed as g%.
Statistical analysis
The results of all the parameters were expressed as mean±standard 
deviation. Student t-test was done to assess the statistical significance 
between two groups. The association between the parameters was 
done by the correlation coefficient.
RESULTS
Our present study was done on 204 Type-II diabetes and 40 healthy 
subjects. A direct relationship was found between serum free iron 
and Type-II DM. We found a significant increase in serum free iron 
in Group-I 98.33±51.27 (p<0.01) when compared with Group-II 
78.07±33.13 (Table 1).
In this study, we found a significant positive correlation between the 
serum free iron and FBS (r=0.43; p<0.001) (Fig. 1) and HbA1c (r=0.59; 
p<0.001) (Fig. 2), respectively.
DISCUSSION
In this present study, we have observed a significant increase in serum 
free iron in Group-I cases, compared to Group-II cases who were 
in good glycemic control [19]. Hyperglycemia observed in Group-I 
causes increased glycation of protein and releases the iron in its free 
state. Several studies have shown that serum free iron is significantly 
increased in Type-II DM [20,21]. This observation is contradicted 
by the studies of EI-Nabarawy et al. [1]. Glycemic control reflects 
the interaction between hyperinsulinemia with iron. This is further 
supported by evidence suggesting that hyperglycemia precedes the 
elevation of iron in diabetes [22,23].
In this present study, we found a positive correlation between FBS and 
free iron as well as free iron and HbA1c in Group I. Increased glycation 
of proteins as a result of poor glycemic control triggers the increased 
release of free iron from glycated proteins like hemoglobin which 
generates a vicious cycle of hyperglycemia, glycation of hemoglobin, 
and increase in levels of free iron [18]. The relationship between free 
iron and Type-2 diabetes is bidirectional [24]. Insulin influences the 
iron uptake and storage by increasing the cell surface transferring 
receptors [25], reciprocally iron influences the insulin activity by 
interfering with glucose uptake and utilization [26]. This increased 
presence of free iron pool will enhance oxidant generation leading 
damage to biomolecules [8]. Free iron is known to induce oxidation 
of biomolecules through Fenton’s and Haber–Weiss reaction by 
producing harmful hydroxyl radicals [8,24]. Free radical formation 
may play a role in the pathogenesis of diabetes by disrupting insulin 
action and total body glucose disposal. The iron act as a powerful pro-
oxidant and the oxidative stress is increased in glucose-intolerant 
states [27-29]. The presence of poor glycemic control, hyperglycemia, 
iron overload, and protein glycation will all lead to oxidative stress 
causing the early appearance of microvascular complications 
(retinopathy and nephropathy) [8,24,30]. The limitations of the 
present study, we have not assessed the markers of oxidative stress 
and insulin resistance.
CONCLUSION
The significantly increased serum free iron and HbA1c in DM reveals 
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